| REVUMENIB 
| REVUMENIB | ANTINEOPLASTIC MENIN INHIBITOR TREATMENT OF ACUTE LEUKEMIA | ORAL | Cmax 5.1 MICROMOLAR Tmax 2 HOUR VD 78 LITER PPB 90 PERCENT Cl 7 LITER / HOUR HT 7.5 HOUR SOLUBILITY SOLUBLE AT PH 1.2 AND 6.8 | MENIN PDB 7UJ4 (INHIBITION OF HUMAN MENIN BY SNDX-5613) LIGAND CODE = OQ4 (link to the list of PDB complexes) Download experimental 3D coordinates of OQ4 with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |